Stocks and InvestingStocks and Investing
Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023
Sat, April 1, 2023
Fri, March 31, 2023

Mason Carrico Initiated (TXG) at Buy and Held Target at $65 on, Mar 31st, 2023


Published on 2024-10-28 02:31:01 - WOPRAI, Mason Carrico
  Print publication without navigation


Mason Carrico of Stephens & Co., Initiated "10x Genomics, Inc." (TXG) at Buy and Held Target at $65 on, Mar 31st, 2023.

Mason has made no other calls on TXG in the last 4 months.



There are 5 other peers that have a rating on TXG. Out of the 5 peers that are also analyzing TXG, 1 agrees with Mason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • John Sourbeer of "UBS" Initiated at Hold and Held Target at $50 on, Thursday, February 2nd, 2023


These are the ratings of the 4 analyists that currently disagree with Mason


  • Dan Brennan of "Cowen & Co." Maintained at Buy with Increased Target to $57 on, Thursday, February 16th, 2023
  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $58 on, Thursday, February 16th, 2023
  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $65 on, Thursday, February 16th, 2023
  • Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $50 on, Wednesday, December 14th, 2022